Wedbush Securities Inc Global Blood Therapeutics, Inc. Transaction History

Wedbush Securities Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 21, 2022	BUY	$22.3 - $37.39 $144,325 - $241,988	6,472 New	6,472 $206,000
Q1 2020 Apr 17, 2020	SELL	$41.72 - $87.2 $134,964 - $282,092	-3,235 Closed	0 $0
Q4 2019 Jan 16, 2020	BUY	$45.7 - $81.86 $147,839 - $264,817	3,235 New	3,235 $257,000
Q3 2018 Nov 13, 2018	SELL	$38.0 - $51.1 $307,420 - $413,399	-8,090 Closed	0 $0
Q2 2018 Aug 03, 2018	BUY	$38.7 - $50.15 $313,083 - $405,713	8,090 New	8,090 $366,000
Q1 2018 May 01, 2018	SELL	$39.6 - $65.9 $289,476 - $481,729	-7,310 Closed	0 $0
Q4 2017 Feb 09, 2018	BUY	$29.7 - $45.7 $217,107 - $334,067	7,310	7,310 $288,000

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Wedbush Securities Inc, based on Form 13F filings with the SEC.

Stay updated on Wedbush Securities Inc with notifications on news.